Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2591-17-5

Post Buying Request

2591-17-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2591-17-5 Usage

Chemical Properties

off-white to light yellow powder

Uses

Different sources of media describe the Uses of 2591-17-5 differently. You can refer to the following data:
1. In the assay of ATP.
2. D-Luciferin has been used in determining luciferase activity by luciferase assay in mice and Arabidopsis thaliana seeds. It has also been used in measuring bioluminescence in neonatal rat ventricular cardiomyocytes.
3. D-Luciferin has been used in the preparation of the reaction mixture for nitric oxide determination by minescence measurement. It has also been used in the preparation of D-luciferin stock solution for luciferin assays.

Definition

ChEBI: A 1,3-thiazolemonocarboxylic acid consisting of 3,5-dihydrothiophene-4-carboxylic acid having a 6-hydroxybenzothiazol-2-yl group at the 2-position.

General Description

D-Luciferin is a small molecule present abundantly in bioluminescent organisms. This molecule is sensitive to oxygen and light.

Biochem/physiol Actions

D-Luciferin uptake within the cells is regulated by the adenosine triphosphate (ATP)-binding cassette (ABC) transporter inhibitors like ATP-binding cassette transporter G2 (ABCG2)/ breast cancer resistance protein (BCRP) inhibitor fumitremorgin C. This substrate is oxidized by firefly luciferase that results in emitting a photon, which has the capability of passing through living tissues.

Purification Methods

D-Luciferin crystallises as pale yellow needles from H2O, or MeOH (83mg/7mL). It has UV max at 263 and 327nm (log 3.88 and 4.27) in 95% EtOH. The Na salt has a solubility of 4mg in 1 mL of 0.05M glycine. [White et al. J Am Chem Soc 83 2402 1961, 85 337 1963, UV and IR: Bitler & McElroy Arch Biochem 72 358 1957, Review: Cormier et al. Fortschr Chem Org Naturst 30 1 1973, Beilstein 27 III/IV 8934.]

Check Digit Verification of cas no

The CAS Registry Mumber 2591-17-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,9 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2591-17:
(6*2)+(5*5)+(4*9)+(3*1)+(2*1)+(1*7)=85
85 % 10 = 5
So 2591-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H8N2O3S2/c14-5-1-2-6-8(3-5)18-10(12-6)9-13-7(4-17-9)11(15)16/h1-3,7,14H,4H2,(H,15,16)

2591-17-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A5030)  D-(-)-Luciferin [Chemiluminescence Reagent]  >98.0%(HPLC)

  • 2591-17-5

  • 10mg

  • 1,280.00CNY

  • Detail
  • TCI America

  • (A5030)  D-(-)-Luciferin [Chemiluminescence Reagent]  >98.0%(HPLC)

  • 2591-17-5

  • 50mg

  • 3,980.00CNY

  • Detail

2591-17-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Photinus luciferin

1.2 Other means of identification

Product number -
Other names (S)-2-(6-Hydroxy-2-benzothiazolyl)-2-thiazoline-4-carboxylic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2591-17-5 SDS

2591-17-5Synthetic route

D-cysteine
921-01-7

D-cysteine

2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
In water at 20℃;95%
With ammonia; sodium In methanol; water94%
Stage #1: D-cysteine; 2-cyano-6-hydroxybenzothiazole In aq. buffer for 1h;
Stage #2: With ATP; magnesium chloride; zinc(II) chloride; luciferase In aq. buffer
27%
D-cysteine hydrochloride
32443-99-5

D-cysteine hydrochloride

2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With potassium carbonate In methanol; water for 0.333333h; Inert atmosphere;86%
With potassium carbonate In water; acetonitrile at 20℃; for 0.333333h;86%
With potassium carbonate In methanol; water for 0.0833333h; Yield given;
With potassium carbonate In methanol for 8h; Concentration; Reagent/catalyst; Inert atmosphere;22.76g
l-cysteine hydrochloride
52-89-1

l-cysteine hydrochloride

2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Stage #1: l-cysteine hydrochloride; 2-cyano-6-hydroxybenzothiazole In methanol; water at 20℃; for 0.0833333h; Inert atmosphere;
Stage #2: With potassium carbonate In methanol; water at 20℃; for 0.333333h; Inert atmosphere;
86%
With potassium carbonate In methanol; dichloromethane; water for 0.166667h; Cooling with ice;80%
S,S-cystine
349-46-2

S,S-cystine

2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
(i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH; Multistep reaction;
luciferin 2-nitro-5-methylbenzenesulfonate
918400-82-5

luciferin 2-nitro-5-methylbenzenesulfonate

GLUTATHIONE
70-18-8

GLUTATHIONE

A

2-amino-4-[1-(carboxymethyl-carbamoyl)-2-(5-methyl-2-nitro-phenylsulfanyl)-ethylcarbamoyl]-butyric acid

2-amino-4-[1-(carboxymethyl-carbamoyl)-2-(5-methyl-2-nitro-phenylsulfanyl)-ethylcarbamoyl]-butyric acid

B

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With human glutathione S-transferase P1-1 In various solvent(s) at 20℃; for 0.5h; Enzyme kinetics; Further Variations:; Reagents;
luciferin 2-nitro-4-methylbenzenesulfonate
918400-81-4

luciferin 2-nitro-4-methylbenzenesulfonate

GLUTATHIONE
70-18-8

GLUTATHIONE

A

2-amino-4-[1-(carboxymethyl-carbamoyl)-2-(4-methyl-2-nitro-phenylsulfanyl)-ethylcarbamoyl]-butyric acid

2-amino-4-[1-(carboxymethyl-carbamoyl)-2-(4-methyl-2-nitro-phenylsulfanyl)-ethylcarbamoyl]-butyric acid

B

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With human glutathione S-transferase A1-1 In various solvent(s) at 20℃; for 0.5h; Enzyme kinetics;
6-methoxybenzothiazol-2-ylamine
1747-60-0

6-methoxybenzothiazol-2-ylamine

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) AcOH, aq. H2SO4, aq. NaNO2, 2.) NaHCO3 / 1.) 1 h, 2.) water, 30 min
2: 81 percent / pyridinium chloride / 0.75 h / 200 °C
3: K2CO3 / methanol; H2O / 0.08 h
View Scheme
2-cyano-6-methoxybenzothiazole
943-03-3

2-cyano-6-methoxybenzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / pyridinium chloride / 0.75 h / 200 °C
2: K2CO3 / methanol; H2O / 0.08 h
View Scheme
Multi-step reaction with 2 steps
1: Py*HCl / 200 °C
2: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
Multi-step reaction with 2 steps
1: pyridine hydrochloride / 1 h / 180 °C / Neat (no solvent); Inert atmosphere
2: potassium carbonate / methanol; water / 0.33 h / Inert atmosphere
View Scheme
6-ethoxybenzothiazole-2-sulfonamide
452-35-7

6-ethoxybenzothiazole-2-sulfonamide

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylsulfoxide / 2.5 h / 125 °C
2: Py*HCl / 2 h / 185 - 195 °C
3: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
ethyl 4'-methoxyoxanilate
18522-99-1

ethyl 4'-methoxyoxanilate

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: (i) P2S5, xylene, (ii) K3, aq. NaOH
2: HCl
3: NH3 / methanol
4: POCl3
5: Py*HCl / 200 °C
6: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
Multi-step reaction with 6 steps
1: (i) P2S5, xylene, (ii) K3, aq. NaOH
2: methanol; diethyl ether
3: NH3 / methanol
4: POCl3
5: Py*HCl / 200 °C
6: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
6-ethoxy-benzothiazole-2-carbonitrile
91634-13-8

6-ethoxy-benzothiazole-2-carbonitrile

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Py*HCl / 2 h / 185 - 195 °C
2: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
6-methoxybenzothiazole-2-carboxamide
946-12-3

6-methoxybenzothiazole-2-carboxamide

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: POCl3
2: Py*HCl / 200 °C
3: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
6-methoxybenzo[d]thiazol-2-carboxylic acid
946-13-4

6-methoxybenzo[d]thiazol-2-carboxylic acid

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: HCl
2: NH3 / methanol
3: POCl3
4: Py*HCl / 200 °C
5: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
Multi-step reaction with 5 steps
1: methanol; diethyl ether
2: NH3 / methanol
3: POCl3
4: Py*HCl / 200 °C
5: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
6-methoxy-benzothiazole-2-carboxylic acid methyl ester
884-22-0

6-methoxy-benzothiazole-2-carboxylic acid methyl ester

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: NH3 / methanol
2: POCl3
3: Py*HCl / 200 °C
4: (i) Na, liq. NH3, (ii) /BRN= 744134/, aq. MeOH
View Scheme
C27H22N4O8S3

C27H22N4O8S3

A

C16H16N2O6S

C16H16N2O6S

B

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With sodium chloride; TEM-1 β-lactamase In phosphate buffer at 25℃; pH=7.4; Enzyme kinetics;
(S)-2-(6'-(2-nitrobenzyloxy)-2'-benzothiazolyl)-Δ2-thiazoline-4-carboxylic acid
1186015-41-7

(S)-2-(6'-(2-nitrobenzyloxy)-2'-benzothiazolyl)-Δ2-thiazoline-4-carboxylic acid

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
In lead(II) sulfide Quantum yield; UV-irradiation;
(S)-2-(6'-(4,5-dimethoxy-2-nitrobenzyloxy)-2'-benzothiazolyl)-Δ2-thiazoline-4-carboxylic acid
1186015-42-8

(S)-2-(6'-(4,5-dimethoxy-2-nitrobenzyloxy)-2'-benzothiazolyl)-Δ2-thiazoline-4-carboxylic acid

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
In lead(II) sulfide Quantum yield; UV-irradiation;
(S)-2-(6'-(1-(2-nitrophenyl)ethoxy)-2'-benzothiazolyl)-Δ2-thiazoline-4-carboxylic acid
1186015-43-9

(S)-2-(6'-(1-(2-nitrophenyl)ethoxy)-2'-benzothiazolyl)-Δ2-thiazoline-4-carboxylic acid

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
In lead(II) sulfide Quantum yield; UV-irradiation;
(4-methoxyphenyl)carbamothioyl cyanide
4968-41-6

(4-methoxyphenyl)carbamothioyl cyanide

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: copper(l) iodide; tetrabutylammomium bromide; palladium dichloride / dimethyl sulfoxide; N,N-dimethyl-formamide / 3 h / 120 °C / Inert atmosphere
2: pyridine hydrochloride / 1 h / 180 °C / Neat (no solvent); Inert atmosphere
3: potassium carbonate / methanol; water / 0.33 h / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: palladium dichloride; copper(l) iodide; tetrabutylammomium bromide / N,N-dimethyl-formamide; dimethyl sulfoxide / 2 h / 120 °C
2: pyridine hydrochloride / sulfolane / 180 °C / Sealed tube; Inert atmosphere
3: potassium carbonate / acetonitrile; water / 0.33 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: palladium dichloride; copper(l) iodide; tetrabutylammomium bromide / Inert atmosphere
2: pyridine hydrochloride / Inert atmosphere
3: Inert atmosphere
View Scheme
4-methoxy-aniline
104-94-9

4-methoxy-aniline

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: dichloromethane / 1 h / 20 °C / Inert atmosphere
1.2: 20 °C / Inert atmosphere
2.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / -5 °C
3.1: copper(l) iodide; tetrabutylammomium bromide; palladium dichloride / dimethyl sulfoxide; N,N-dimethyl-formamide / 3 h / 120 °C / Inert atmosphere
4.1: pyridine hydrochloride / 1 h / 180 °C / Neat (no solvent); Inert atmosphere
5.1: potassium carbonate / methanol; water / 0.33 h / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1.1: sulfolane / 3.33 h / 40 - 180 °C / Sealed tube; Inert atmosphere
1.2: 1 h / 180 °C / Sealed tube; Inert atmosphere
2.1: potassium carbonate / acetonitrile; water / 0.33 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: sulfolane / 3.33 h / 40 - 180 °C / Sealed tube; Inert atmosphere
1.2: 1 h / 180 °C / Sealed tube; Inert atmosphere
2.1: pyridine hydrochloride / sulfolane / 180 °C / Sealed tube; Inert atmosphere
3.1: potassium carbonate / acetonitrile; water / 0.33 h / 20 °C
View Scheme
N-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-4-methoxyaniline
75318-49-9

N-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-4-methoxyaniline

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / -5 °C
2: copper(l) iodide; tetrabutylammomium bromide; palladium dichloride / dimethyl sulfoxide; N,N-dimethyl-formamide / 3 h / 120 °C / Inert atmosphere
3: pyridine hydrochloride / 1 h / 180 °C / Neat (no solvent); Inert atmosphere
4: potassium carbonate / methanol; water / 0.33 h / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: pyridine hydrochloride / sulfolane / 1 h / 180 °C
2: potassium carbonate / acetonitrile; water / 0.33 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: pyridine hydrochloride / sulfolane / 1 h / 180 °C
2: pyridine hydrochloride / sulfolane / 180 °C / Sealed tube; Inert atmosphere
3: potassium carbonate / acetonitrile; water / 0.33 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: 1,8-diazabicyclo[5.4.0]undec-7-ene / Inert atmosphere
2: palladium dichloride; copper(l) iodide; tetrabutylammomium bromide / Inert atmosphere
3: pyridine hydrochloride / Inert atmosphere
4: Inert atmosphere
View Scheme
(S)-2-( 6-(4-borono-3-fluorobenzyloxy)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid
1622311-98-1

(S)-2-( 6-(4-borono-3-fluorobenzyloxy)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With water; 3-morpholinosydnonymine; 2-amino-2-hydroxymethyl-1,3-propanediol In aq. buffer at 37℃; for 1h; pH=8.5; Kinetics; Reagent/catalyst;
(S)-2-(6-(4-boronobenzyloxy)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid

(S)-2-(6-(4-boronobenzyloxy)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With water; 3-morpholinosydnonymine; 2-amino-2-hydroxymethyl-1,3-propanediol In aq. buffer at 37℃; for 1.5h; pH=8.5; Kinetics; Reagent/catalyst; Time;
2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: cesium chloride / N,N-dimethyl-formamide / 60 °C
2.1: potassium carbonate / water; dichloromethane; methanol / Inert atmosphere
2.2: Inert atmosphere
3.1: water; 3-morpholinosydnonymine; 2-amino-2-hydroxymethyl-1,3-propanediol / aq. buffer / 1 h / 37 °C / pH 8.5
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate / N,N-dimethyl-formamide / 24 h / 70 °C
2: potassium carbonate / water; methanol / 1 h / 20 °C / pH 8 / Inert atmosphere; Darkness
3: ozone; pyrrolidine / aq. phosphate buffer; dimethyl sulfoxide / 1 h / 37 °C / pH 7
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate / acetonitrile / 90 °C
2: potassium carbonate / methanol; water / 20 °C
3: oxygen; cobalt(II) chloride
View Scheme
Multi-step reaction with 2 steps
1.1: potassium carbonate / acetonitrile / Inert atmosphere
1.2: Inert atmosphere
2.1: oxygen; tyrosinase / aq. acetate buffer / 3 h / 37 °C / pH 7.4 / Enzymatic reaction
View Scheme
C13H12N2O3S2

C13H12N2O3S2

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With pig liver esterase In aq. phosphate buffer at 37℃; for 24h; Inert atmosphere; Enzymatic reaction;
2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

A

C14H12N2O4S2

C14H12N2O4S2

B

C14H14N2O5S2

C14H14N2O5S2

C

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate / N,N-dimethyl-formamide / 24 h / 70 °C
2: potassium carbonate / water; methanol / 1 h / 20 °C / pH 8 / Inert atmosphere; Darkness
3: ozone / aq. phosphate buffer; dimethyl sulfoxide / 1 h / 37 °C / pH 7
View Scheme
2-cyano-6-(3-butenyloxy)benzothiazole

2-cyano-6-(3-butenyloxy)benzothiazole

A

C14H12N2O4S2

C14H12N2O4S2

B

C14H14N2O5S2

C14H14N2O5S2

C

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / water; methanol / 1 h / 20 °C / pH 8 / Inert atmosphere; Darkness
2: ozone / aq. phosphate buffer; dimethyl sulfoxide / 1 h / 37 °C / pH 7
View Scheme
2-cyano-6-(3-butenyloxy)benzothiazole

2-cyano-6-(3-butenyloxy)benzothiazole

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / water; methanol / 1 h / 20 °C / pH 8 / Inert atmosphere; Darkness
2: ozone; pyrrolidine / aq. phosphate buffer; dimethyl sulfoxide / 1 h / 37 °C / pH 7
View Scheme
C15H14N2O3S2

C15H14N2O3S2

A

C14H12N2O4S2

C14H12N2O4S2

B

C14H14N2O5S2

C14H14N2O5S2

C

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With ozone In aq. phosphate buffer; dimethyl sulfoxide at 37℃; for 1h; pH=7;
C15H14N2O3S2

C15H14N2O3S2

D-luciferin
2591-17-5

D-luciferin

Conditions
ConditionsYield
With pyrrolidine; ozone In aq. phosphate buffer; dimethyl sulfoxide at 37℃; for 1h; pH=7; Reagent/catalyst;
D-luciferin
2591-17-5

D-luciferin

hydrazone of 2-nitroacetophenone
116271-34-2

hydrazone of 2-nitroacetophenone

C19H15N3O5S2

C19H15N3O5S2

Conditions
ConditionsYield
Stage #1: hydrazone of 2-nitroacetophenone With manganese(IV) oxide In dichloromethane at -20℃; for 1h;
Stage #2: D-luciferin In methanol; dichloromethane Cooling with ice;
69.4%
D-luciferin
2591-17-5

D-luciferin

2-(6’-hydroxy-2'-benzothiazolyl)-thiazole-4-carboxylic acid
20115-09-7

2-(6’-hydroxy-2'-benzothiazolyl)-thiazole-4-carboxylic acid

Conditions
ConditionsYield
With oxygen; sodium hydroxide65%
With sodium hydroxide Heating;
D-luciferin
2591-17-5

D-luciferin

N-acetyl-4,7,8,9-tetra-O-acetyl-2-chloro-2-deoxyneuraminic acid methyl ester
67670-69-3

N-acetyl-4,7,8,9-tetra-O-acetyl-2-chloro-2-deoxyneuraminic acid methyl ester

luciferyl N-acetylneuraminic acid

luciferyl N-acetylneuraminic acid

Conditions
ConditionsYield
Stage #1: D-luciferin With sodium hydroxide In water at 0 - 20℃; Inert atmosphere; Darkness;
Stage #2: N-acetyl-4,7,8,9-tetra-O-acetyl-2-chloro-2-deoxyneuraminic acid methyl ester With sodium iodide dihydrate; sodium hydroxide In water; acetone at 20℃; for 2h; pH=9 - 10; Inert atmosphere; Darkness;
Stage #3: With sodium hydroxide In methanol; water for 1h;
43%
methanol
67-56-1

methanol

D-luciferin
2591-17-5

D-luciferin

(S)-methyl 2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate
73918-26-0

(S)-methyl 2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate

Conditions
ConditionsYield
With pyridine; dicyclohexyl-carbodiimide for 3h; Inert atmosphere;42%
With thionyl chloride at 20℃; for 1h;
tert-butylsulfinyl chloride
31562-43-3

tert-butylsulfinyl chloride

D-luciferin
2591-17-5

D-luciferin

C15H16N2O4S3

C15H16N2O4S3

Conditions
ConditionsYield
With sodium hydroxide In water at 0 - 20℃; for 2h; Inert atmosphere;40%
D-luciferin
2591-17-5

D-luciferin

2,4-Dinitrofluorobenzene
70-34-8

2,4-Dinitrofluorobenzene

C17H10N4O7S2

C17H10N4O7S2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 25℃; for 2h;30%
C18H28ClNO10
1400692-83-2

C18H28ClNO10

D-luciferin
2591-17-5

D-luciferin

luciferyl 4,7-di-O-methyl-N-acetylneuraminic acid

luciferyl 4,7-di-O-methyl-N-acetylneuraminic acid

Conditions
ConditionsYield
Stage #1: D-luciferin With sodium hydroxide In water at 0 - 20℃; Darkness; Inert atmosphere;
Stage #2: C18H28ClNO10 With sodium iodide dihydrate; sodium hydroxide In water; acetone at 20℃; for 2.42h; pH=9 - 10; Inert atmosphere; Darkness;
Stage #3: With sodium hydroxide In methanol; water for 1h;
28%
D-luciferin
2591-17-5

D-luciferin

(S)-2-(6-Hydroxy-7-iodo-benzothiazol-2-yl)-4,5-dihydro-thiazole-4-carboxylic acid

(S)-2-(6-Hydroxy-7-iodo-benzothiazol-2-yl)-4,5-dihydro-thiazole-4-carboxylic acid

Conditions
ConditionsYield
With chloroamine-T; sodium iodide In ethanol at 20℃; for 0.166667h;22%
4-(bromomethyl)phenyl 2-methylpropane-2-sulfinate

4-(bromomethyl)phenyl 2-methylpropane-2-sulfinate

D-luciferin
2591-17-5

D-luciferin

C22H22N2O5S3

C22H22N2O5S3

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 0 - 20℃; for 3.5h; Inert atmosphere;12%
D-luciferin
2591-17-5

D-luciferin

D-(-)-2-(6'-hydroxy-7'-[123I]iodobenzothiazolyl)-Δ2-thiazoline-4-carboxylic acid

D-(-)-2-(6'-hydroxy-7'-[123I]iodobenzothiazolyl)-Δ2-thiazoline-4-carboxylic acid

Conditions
ConditionsYield
With [123I] sodium iodide; chloroamine-T In ethanol at 20℃; for 0.0833333h;
D-luciferin
2591-17-5

D-luciferin

[11C]methyl triflate
145577-00-0

[11C]methyl triflate

C11(11)CH10N2O3S2

C11(11)CH10N2O3S2

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydroxide In methanol; acetonitrile at 70 - 80℃; for 0.0333333h;
D-luciferin
2591-17-5

D-luciferin

2-(6-hydroxy-1,3-benzothiazol-2-yl)-1,3-thiazol-4(5H)-one
17002-50-5

2-(6-hydroxy-1,3-benzothiazol-2-yl)-1,3-thiazol-4(5H)-one

Conditions
ConditionsYield
With oxygen; rose bengal; ATP; firefly luciferase In water at 25℃; pH=7.8; Kinetics; Further Variations:; Reagents;
Multi-step reaction with 2 steps
1: triethylamine / N,N-dimethyl-formamide
2: triethylamine; oxygen / N,N-dimethyl-formamide
View Scheme
With firefly luciferase; oxygen; ATP; magnesium chloride In aq. buffer at 20℃; Concentration; Enzymatic reaction;
D-luciferin
2591-17-5

D-luciferin

2-(6-acetoxy-benzothiazol-2-yl)-thiazole-4-carboxylic acid methyl ester

2-(6-acetoxy-benzothiazol-2-yl)-thiazole-4-carboxylic acid methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NaOH / Heating
2: (i) MeOH, Et2O, (ii) /BRN= 385737/, Py
View Scheme
D-luciferin
2591-17-5

D-luciferin

2-thiazol-2-yl-benzothiazol-6-ol
63565-77-5

2-thiazol-2-yl-benzothiazol-6-ol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NaOH / Heating
2: 150 °C
View Scheme

2591-17-5Relevant articles and documents

A simple bioluminescent method for measuring d-amino acid oxidase activity

Bailey, T. Spencer,Donor, Micah T.,Naughton, Sean P.,Pluth, Michael D.

, p. 5425 - 5428 (2015)

d-Amino acid oxidase (DAO) plays important roles in regulating d-amino acid neurotransmitters and was recently identified as a key enzyme integral to hydrogen sulfide production from d-Cys. We report here the development of a simple biocompatible, bioluminescent method for measuring DAO activity based on the highly selective condensation of d-Cys with 6-hydroxy-2-cyanobenzothiazole (CBT-OH) to form d-luciferin. This journal is

A Convenient Synthetic Method of 2-Cyano-6-methoxybenzothiazole, - A Key Intermediate for the Synthesis of Firefly Luciferin

Toya, Yoshiaki,Takagi, Masaharu,Nakata, Hisao,Suzuki, Nobutaka,Isobe, Minoru,Goto, Toshio

, p. 392 - 395 (1992)

The title compound was prepared in one step from commercially available 2-amino-6-methoxybenzothiazole by using the Sandmeyer cyanation reaction.The result enabled us to synthesize firefly luciferin effectively from this amino compound through three steps in 36percent overall yield.

Specific Imaging of Tyrosinase in Vivo with 3-Hydroxybenzyl Caged D -Luciferins

Li, Shuang,Hu, Rui,Wang, Shuangqing,Guo, Xudong,Zeng, Yi,Li, Yi,Yang, Guoqiang

, p. 9296 - 9300 (2018)

Tyrosinase (TYR), a key enzyme in biosynthesis of melanin, usually functions as a biomarker of severe skin diseases such as vitiligo and melanoma cancer. Accurate detection of TYR activity in vivo is urgent but still challenging. Inspired by the advantages of bioluminescence in vivo strategy in imaging and the specific hydroxylation of 3-hydroxybenzyloxy group by TYR, a bioluminogenic probe, TYR-LH2, was designed and synthesized through caging D-luciferin with 3-hydroxybenzyl. The probe exhibits high selectivity and sensitivity toward TYR with a detection limit of 0.11 U/mL in a small detection volume of 100 μL. Bioluminescence imaging results show that TYR-LH2 is fully competent for monitoring the dynamic changes of TYR in living cells and model animals and possesses the capability of discriminating melanocytes from other cell lines, thus offering a promising approach for investigation and diagnosis of melanoma cancer and other TYR-related diseases in vivo.

A bioluminescent probe for imaging endogenous hydrogen polysulfides in live cells and a murine model of bacterial infection

Li, Jun-Bin,Wang, Qianqian,Liu, Hong-Wen,Yuan, Lin,Zhang, Xiao-Bing

, p. 4487 - 4490 (2019)

In this work, we report the first bioluminescent probe BP-PS for detecting H2Sn with high specificity and sensitivity. Owing to the bioluminescence imaging without requiring an excitation light source, tissue autofluorescence is eliminated and BP-PS shows a high signal-to-noise ratio. Moreover, BP-PS was successfully utilized to visualize endogenous H2Sn in live cells and a murine model of bacterial infection.

Highly sensitive and selective bioluminescence based ozone probes and their applications to detect ambient ozone

Nam, Younseok,Kim, Beom Seok,Shin, Injae

, p. 1128 - 1130 (2016)

Highly selective and sensitive bioluminescence based probes, which respond to ozone but not to other ROS, have been developed. These probes were used to determine ozone concentrations in environmental samples.

Computation-Guided Rational Design of a Peptide Motif That Reacts with Cyanobenzothiazoles via Internal Cysteine-Lysine Relay

Keyser, Samantha G. L.,Utz, Ashley,Bertozzi, Carolyn R.

, p. 7467 - 7479 (2018)

Site-selective protein modification based on covalent reactions of peptide tags and small molecules is a key capability for basic research as well as for the development of new therapeutic bioconjugates. Here, we describe the computation-guided rational design of a cysteine- and lysine-containing 11-residue peptide sequence that reacts with 2-cyanobenzothiazole (CBT) derivatives. Our data show that the cysteine residue reversibly reacts with the nitrile group on the CBT moiety to form an intermediate thioimidate, which undergoes irreversible SN transfer to the lysine residue, yielding an amidine-linked product. The concepts outlined herein lay a foundation for future development of peptide tags in the context of site-selective modification of lysine residues within engineered microenvironments.

Using Bioluminescence Turn-On to Detect Cysteine in Vitro and in Vivo

Zhang, Miaomiao,Wang, Lin,Zhao, Yangyang,Wang, Fuqiang,Wu, Jindao,Liang, Gaolin

, p. 4951 - 4954 (2018)

Cysteine (Cys) is an essential amino acid and plays important roles in many biological processes. Bioluminescence (BL) is advantageous in sensitivity but BL probes that were intentionally developed for the selective detection of Cys were rarely reported. Herein, employing a fast conjugate addition between Cys and acrylic ester, we synthesized a caged BL probe acrylic ester luciferin (1) and used it to selectively detect Cys in vitro and image Cys in living cells and in tumor sites. We envision that, in the future, probe 1 might be used for evaluating the Cys roles in more biological processes.

Synthesis and evaluation of D-thioluciferin, a bioluminescent 6'-thio analog of Dluciferin

Rylands, Marwaan,Jardine, Anwar

, p. 176 - 189 (2021/03/17)

All known light-emitting firefly-bioluminescent luciferin analogs are either derived from the 6'-hydroxy- and/or 6'-aminoluciferin. We report the synthesis of D-thioluciferin, a 6'-thio analog or isostere of D-luciferin, starting from p-aminothiophenol, using a unique thioacrylate-S-protecting-group strategy. Upon treatment of Dthioluciferin with purified Photinus pyralis (Ppy) luciferase (Luc), a bioluminescence emission with a red-shift λmax relative to D-luciferin was observed. It was also shown that disulphide and sulphide analogs of Dthioluciferin did not produce similar bioluminescences relative to D-thioluciferin when treated with Ppy Luc under standard conditions, thus, providing a foundation for the development of D-thioluciferin based probes based on disulphide reduction and S-dealkylation.

DERIVATIVES OF LUCIFERIN AND METHODS FOR THEIR SYNTHESIS

-

Page/Page column 28, (2019/02/13)

6-Thio derivatives of D-luciferin, also referred to as D-thioluciferins, having the general structure of Formula (I) are provided. Methods for synthesising D-luciferin, its derivatives, and their related 2-cyanobenzothiazole precursors are also provided. These compounds are commercially valuable due to their application in optical imaging, particularly in bioluminescence imaging.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2591-17-5